Google promises to protect privacy as it eyes opportunities in health care

More news out of Davos, Switzerland, from Alphabet Inc. CEO Sundar Pichai: Health care looks to be the next big frontier for artificial intelligence. Reuters reports that Pichai, also CEO of Google Inc., told a panel at the World Economic Forum in Davos that artificial intelligence has the potential to improve health outcomes in the next five to 10 years. “Look at the potential here. Cancer (is) often missed and the difference in outcome is profound. In lung cancer, for example, five experts…
Source: Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news

Related Links:

Researchers determined that artificial intelligence could help predict responses to systemic therapies for patients with non-small cell lung cancer by utilizing CT scans.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Source Type: news
CONCLUSION: Although tumor burden has been considered a mediator of efficacy of earlier immunotherapies, in advanced lung cancer it does not appear to affect outcomes from immune checkpoint inhibitors. IMPLICATIONS FOR PRACTICE: Historically, tumor burden has been considered an impediment to the efficacy of various immunotherapies, including vaccines, cytokines, allogeneic stem cell transplant, and intravesical bacillus Calmette-Guérin. However, in the present study, no association was found between tumor burden and efficacy (response rate, progression-free survival, overall survival) of immune checkpoint inhib...
Source: The Oncologist - Category: Cancer & Oncology Authors: Tags: Oncologist Source Type: research
Studies suggesting artificial intelligence is as good or better than doctors at interpreting medical images are of poor quality Related items fromOnMedica Sentinel node biopsy first to check spread of oral cancer NICE updates lung cancer guidance Benefits of breast screening are overestimated, research suggests Annual mammograms do not cut cancer deaths Ultrasonography needed to check for ectopic pregnancy
Source: OnMedica Latest News - Category: UK Health Source Type: news
Abstract BACKGROUND: Hepatocellular carcinoma (HCC) recurrence and development of de novo malignancy (DNM) after liver transplantation (LT) are the major causes of late recipient death. METHODS: We analyzed the incidence of extrahepatic DNM following living donor LT according to the status of pretransplant hepatic malignancy. We selected 2,076 adult patients who underwent primary LDLT during 7 years from January 2010 to December 2016. RESULTS: The pretransplant hepatic malignancy group (n = 1,012) showed 45 cases (4.4%) of the following extrahepatic DNMs: posttransplant lymphoproliferative disease (PTLD)...
Source: J Korean Med Sci - Category: General Medicine Authors: Tags: J Korean Med Sci Source Type: research
(American Association for Cancer Research) Using standard-of-care computed tomography (CT) scans in patients with advanced non-small cell lung cancer (NSCLC), researchers utilized artificial intelligence (AI) to train algorithms to predict tumor sensitivity to three systemic cancer therapies.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
AbstractObjective: To study the effect and mechanism of Huayu Wan ( 化瘀丸, HYW) in combination of chemotherapy of tumor treatment.Methods: HYW serum was added in Lewis cells to assess its impact on fluorescent doxorubicin delivery in vitro. Then, Lewis tumor cells was implanted in C57BL/6 mice via xenograft transplantation. Tumor growth was measured and signal intensity corresponding to blood flow was assessed by laser doppler perfusion imaging (LDPI). Finally, the effect of HYW on the effificacy of doxorubicin was studied.Results: HYW can improve the transfer of fluorescent doxorubicin into cells. The blood flow signa...
Source: Chinese Journal of Integrative Medicine - Category: Internal Medicine Source Type: research
Over the past 200 years lung diseases have shifted from infections – tuberculosis, pneumonia – to diseases of dirty air – chronic obstructive pulmonary disease, asthma and lung cancer. New diseases have emerged from industrial pollution and HIV infection, while better imaging has revealed others previously unrecognized. Scientific advances in microbiology, im aging and clinical measurement have improved diagnosis and allowed better targeted treatment. Advances in treatment have been dramatic, the most important being drugs (antibiotics, cortisone, β2-adrenoceptor agonists), ventilatory support (from ...
Source: Medicine - Category: Internal Medicine Authors: Tags: Clinical aspects Source Type: research
Abstract OBJECTIVES: In the Asian population, patterns and risk factors for de novo malignancies after solid-organ transplant are not well understood. MATERIALS AND METHODS: Insurance claims from Taiwan's National Health Institute Research Database from 1997 to 2011 revealed 687 deceased-donor heart transplant recipients, 5038 kidney transplant recipients (50% living related-donor, 50% deceased-donor transplants), and 2127 liver transplant recipients (mainly living related-donor transplants, 30% deceased-donor transplants). During the follow-up period, rates of malignancy incidence were calculated with standa...
Source: Experimental and Clinical Transplantation : official journal of the Middle East Society for Organ Transplantation - Category: Transplant Surgery Authors: Tags: Exp Clin Transplant Source Type: research
Abstract PURPOSE: Epidermal growth factor receptor (EGFR) mutation testing has several limitations. Therefore, we built predictive models to determine the EGFR mutation status of patients and guide therapeutic decision-making. METHODS: We collected data from 320 patients with lung carcinoma, including sex, age, smoking history, serum tumour marker levels, maximum standardized uptake value, pathological results, computed tomography images, and EGFR mutation status. Artificial neural network (ANN) models based on multiple clinical characteristics were proposed to predict EGFR mutation status. RESULTS: A tr...
Source: Clinical Lung Cancer - Category: Cancer & Oncology Authors: Tags: J Cancer Res Clin Oncol Source Type: research
A 56-year-old man presented with cervical swelling and back pain. He had been diagnosed with right upper lobe adenocarcinoma developing superior vena cava (SVC) syndrome two years prior. His tumor was invading the lower tracheal lateral wall and tracheobronchial angle (cT4N2M0). He was initially judged as inoperable and offered definitive chemo-radiotherapy (3 cycles cisplatin and vinorelbine with concurrent radiotherapy 66 Gy) followed by atezolizumab with no response. He was referred to us for potential salvage surgery.
Source: Seminars in Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: THORACIC – Case Report Source Type: research
More News: Biotechnology | Cancer | Cancer & Oncology | Eyes | Health Management | Lung Cancer | Lung Transplant | Switzerland Health